NCT00001626View on ClinicalTrials.gov

Comparing Therapies for the Treatment of Severe Aplastic Anemia

PHASE2CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

June 2, 1997

Primary Completion Date

February 20, 2001

Study Completion Date

March 3, 2008

Conditions
Severe Aplastic Anemia (SAA)
Interventions
DRUG

antithymocyte globulin

antithymocyte globulin

DRUG

cyclophosphamide

cyclophosphamide

DRUG

cyclosporine

cyclosporine

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00001626 - Comparing Therapies for the Treatment of Severe Aplastic Anemia | Biotech Hunter | Biotech Hunter